Curis
CRIS
#11043
Rank
A$7.54 M
Marketcap
A$0.79
Share price
-13.46%
Change (1 day)
-58.05%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$20.04

According to Curis's latest financial reports the company's current EPS (TTM) is A-$21.21. In 2025 the company made an earnings per share (EPS) of A-$35.51 an increase over its 2024 EPS that were of A-$209.68.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$20.04-43.57%
2025A-$35.51-83.07%
2024A-$209.68-22.15%
2023A-$269.33-26.17%
2022A-$364.7722.3%
2021A-$298.26-25.37%
2020A-$399.67-30.93%
2019A-$578.62-2.02%
2018A-$590.55
2016A-$1,342-10%
2015A-$1,491138.1%
2014A-$626.3540%
2013A-$447.39-25%
2012A-$596.5266.67%
2011A-$357.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.06-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.74-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.54-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$5.16-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.49-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$4.74-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$7.52-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA